Johnson & JohnsonvsSolventum

JNJ and SOLV stock compared: price, dividend, valuation and results, from SEC filings.

SOLV

Solventum Corporation

$88.65

Value $15.4B

-0.48%
SOLV's page

Johnson & Johnson (JNJ) has a market value of $681B and Solventum (SOLV) $15.4B. Over the last year, with dividends, JNJ moved +47.5% and SOLV +17.2%. The P/E is 42.3 for JNJ and 98.6 for SOLV. Dividend yield: JNJ 1.87%, SOLV none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$681B

    SOLV$15.4B

    JNJ is 44 times SOLV

  • Revenue, 12 months

    JNJ$99.3B

    SOLV$8.2B

    JNJ is 12 times SOLV

  • Net income, 12 months

    JNJ$16.1B

    SOLV$156M

    JNJ is 103 times SOLV

  • Operating margin

    JNJ–

    SOLV5.6%

  • ROIC

    JNJ12.4%

    SOLV4.2%

    8.2 points apart

  • P/E

    JNJ42.3

    SOLV98.6

    SOLV is 2.3 times JNJ

  • Dividend yield

    JNJ1.9%

    SOLV0.0%

    1.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+47.5%

SOLV+17.2%

100120140DecFebAprJunAugOct
Returns by period
PeriodJNJWith dividendsSOLVWith dividends
1 year since November 14, 2025+47.5%Price +44.2%+17.2%Price +17.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonSOLVSolventum

Valuation

JNJSOLV
Valuation
Price$282.55$88.65
Market value$681B$15.4B
Enterprise value (EV)$708B$20.2B
P/E42.398.6
P/E, 5-year median21.9–
P/B8.43.2
EV/EBIT39.944.4
Free cash flow yield3.0%–

Results and growth

JNJSOLV
Results and growth
Revenue, 12 months$99.3B$8.2B
Net income, 12 months$16.1B$156M
Free cash flow, 12 months$20.6B$0
Earnings per share, 12 months$6.59$0.88
Revenue growth, year on year6.1%0.9%
Revenue growth a year, past+2.7%over 5 years+0.8%over 3 years
EPS growth a year, past+14.9%over 5 years+4.5%over 3 years

Margins and returns on capital

JNJSOLV
Margins and returns on capital
Gross margin67.6%54.8%
Operating margin–5.6%
Net margin16.2%1.9%
ROIC12.4%4.2%
ROE19.7%3.2%

Balance sheet

JNJSOLV
Balance sheet
Cash$17.2B$451M
Total debt$44.7B$5.3B
Net debt / EBITDA1.15.1
Interest cover18.0×–

Dividends and buybacks

JNJSOLV
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.7%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or SOLV

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Solventum?

By market value, Johnson & Johnson ($681B) is about 44.3 times Solventum ($15.4B), at today's prices.

How did JNJ and SOLV stock do over the last 1 years?

Since November 14, 2025, JNJ's price moved +44.2% and SOLV's +17.2%. With dividends: JNJ +47.5% (+47.5% a year), SOLV +17.2% (+17.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or SOLV?

The dividend yield at today's price is 1.87% for Johnson & Johnson and none for Solventum. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and SOLV?

At today's price, the P/E is 42.3 for JNJ and 98.6 for SOLV. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Johnson & Johnson or Solventum?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 1.9% for Solventum, and the operating margin – and 5.6%. Revenue was $99.3B and $8.2B.

Which is the better investment, Johnson & Johnson or Solventum?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.